DK1012285T3 - Hidtil ukendte beta-defensiner - Google Patents

Hidtil ukendte beta-defensiner

Info

Publication number
DK1012285T3
DK1012285T3 DK98947034T DK98947034T DK1012285T3 DK 1012285 T3 DK1012285 T3 DK 1012285T3 DK 98947034 T DK98947034 T DK 98947034T DK 98947034 T DK98947034 T DK 98947034T DK 1012285 T3 DK1012285 T3 DK 1012285T3
Authority
DK
Denmark
Prior art keywords
new beta
beta defensins
zampl
polypeptides
present
Prior art date
Application number
DK98947034T
Other languages
English (en)
Inventor
Nand Baindur
David Adler
James L Holloway
Stephanie Beigel
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1012285T3 publication Critical patent/DK1012285T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Gyroscopes (AREA)
  • Silicon Polymers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98947034T 1997-09-10 1998-09-10 Hidtil ukendte beta-defensiner DK1012285T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5833597P 1997-09-10 1997-09-10
US92652997A 1997-09-10 1997-09-10
US96468797A 1997-11-05 1997-11-05
US6429497P 1997-11-05 1997-11-05

Publications (1)

Publication Number Publication Date
DK1012285T3 true DK1012285T3 (da) 2005-12-12

Family

ID=27489968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98947034T DK1012285T3 (da) 1997-09-10 1998-09-10 Hidtil ukendte beta-defensiner

Country Status (8)

Country Link
EP (1) EP1012285B1 (da)
JP (1) JP2001515720A (da)
AT (1) ATE301194T1 (da)
AU (1) AU744152B2 (da)
CA (1) CA2303421C (da)
DE (1) DE69831084T2 (da)
DK (1) DK1012285T3 (da)
WO (1) WO1999013080A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000046245A2 (de) * 1999-02-01 2000-08-10 Schering Aktiengesellschaft Humane antibiotische proteine
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
WO2001030846A1 (en) * 1999-10-28 2001-05-03 Zymogenetics, Inc. Beta-defensins
DE19957043A1 (de) * 1999-11-26 2001-06-07 Forssmann Wolf Georg Neue Defensine
AU2001275208A1 (en) * 2000-06-01 2001-12-11 University Of Iowa Research Foundation Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
EP1887015A3 (de) * 2000-07-11 2008-05-07 IPF Pharmaceuticals GmbH Verfahren zur Gewinnung und Anwendung neuer humaner Defensine als biologisch aktive Eiweißstoffe zur Behandlung von Infektionen und anderen Erkrankungen
WO2002040512A2 (de) * 2000-11-14 2002-05-23 Ipf Pharmaceuticals Gmbh Humanes beta-defensin-3
US7119070B2 (en) 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
GB0223655D0 (en) 2002-10-10 2002-11-20 Mabtech Ab Method of diagnosis
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550109A (en) * 1994-05-24 1996-08-27 Magainin Pharmaceuticals Inc. Inducible defensin peptide from mammalian epithelia
CA2297109A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues

Also Published As

Publication number Publication date
AU9391598A (en) 1999-03-29
CA2303421A1 (en) 1999-03-18
ATE301194T1 (de) 2005-08-15
EP1012285B1 (en) 2005-08-03
CA2303421C (en) 2005-07-12
DE69831084D1 (de) 2005-09-08
WO1999013080A1 (en) 1999-03-18
AU744152B2 (en) 2002-02-14
EP1012285A1 (en) 2000-06-28
JP2001515720A (ja) 2001-09-25
DE69831084T2 (de) 2006-06-01

Similar Documents

Publication Publication Date Title
NO20000934D0 (no) Adipocyttspesifikke proteinhomologer
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
ATE380875T1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
DK1002075T3 (da) Adipocyt-specifikke proteinhomologer
DK1012285T3 (da) Hidtil ukendte beta-defensiner
ATE122400T1 (de) Polypeptide mit aktivität gegen gram-positive und gram-negative bakterien.
ATE400294T1 (de) Neue antimikrobielle polypeptide und verfahren für ihre verwendung.
DK1169340T3 (da) Lantibiotikum
ATE313562T1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
PT676413E (pt) Proteina de ligacao a interferoes alfa/beta, sua preparacao e utilizacao
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
WO2000073446A3 (en) Adipocyte complement related protein homolog zacrp6
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
DE69836226D1 (de) Ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
DE69019581D1 (de) Polypeptid und dieses enthaltende antibaktierelle Präparate.
DK0999849T3 (da) Anvendelse af LBP til sepsisbehandling
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.
Critical Care Society of South Africa Working Group Severe sepsis and the role of novel therapeutic agents. Position statement of the Critical Care Society of South Africa on severe sepsis and the role of novel therapeutic agents such as drotrecogin alfa (activated)
WO2001000664A3 (en) Secreted alpha-helical protein-36